Amedisys SG&A Expenses 2010-2024 | AMED

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amedisys sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amedisys sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.5B
Quest Diagnostics (DGX)	$18B
DaVita (DVA)	$12.9B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.2B
Elanco Animal Health (ELAN)	$6.6B
RadNet (RDNT)	$5.9B
Option Care Health (OPCH)	$3.7B
LifeStance Health (LFST)	$2.8B
Astrana Health (ASTH)	$2.3B
Addus HomeCare (ADUS)	$2.2B
U.S Physical Therapy (USPH)	$1.4B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Pennant (PNTG)	$1.1B
Atai Life Sciences (ATAI)	$290M
Daxor (DXR)	$43M
MEDIROM Healthcare Technologies (MRM)	$15M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$8M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M